Compare CCHH & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCHH | SMTI |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.1M | 186.9M |
| IPO Year | 2025 | N/A |
| Metric | CCHH | SMTI |
|---|---|---|
| Price | $14.09 | $23.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | ★ 740.6K | 69.4K |
| Earning Date | 12-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $8,915,344.00 | ★ $101,877,532.00 |
| Revenue This Year | N/A | $21.60 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | $273.98 | ★ N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $3.49 | $18.90 |
| 52 Week High | $14.40 | $38.68 |
| Indicator | CCHH | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.78 |
| Support Level | N/A | $20.06 |
| Resistance Level | N/A | $21.14 |
| Average True Range (ATR) | 0.00 | 1.17 |
| MACD | 0.00 | 0.63 |
| Stochastic Oscillator | 0.00 | 85.79 |
CCH Holdings Ltd operates a hotpot restaurant chain in Malaysia, specializing in chicken hotpot and fish head hotpot, mainly under two brand, namely Chicken Claypot House and Zi Wei Yuan, owned by the wholly owned subsidiaries of the Company. The Company conducts its operations through its wholly owned subsidiaries in Malaysia and is engaged as a restaurant operator, licensor and loyalty owner, and general trader. Currently, the Group has developed a restaurant chain including approximately 15 company-owned restaurant outlets, 13 franchised restaurant outlets in Malaysia, and 4 franchised restaurant outlets outside Malaysia.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.